Biotech and the Hungry Planet:Neal Carter at TEDxPenticton
Neal Carter is president and founder of Okanagan Specialty Fruits trade; (OSF), a biotechnology company specializing in the creation of novel tree fruit varieties. For nearly 30 years Neal has worked with numerous crops as a bioresource engineer around the globe and it was through this firsthand experience that Neal was persuaded that biotechnology can help agriculture meet ever-expanding global food demands and challenges. Carter #39;s goal is to develop safe, high-quality tree fruit cultivars that provide growers, processors, wholesalers, retailers, food service and consumers with improvements in quality and productivity. For TEDxPenticton 2012, "Agricultural biotechnology: saving lives, building communities and feeding the planet into the next century." In thespirit of ideas worth spreading, TEDx is a program of local, self-organized events that bring people together to share a TED-like experience. At a TEDx event, TEDTalks video and live speakers combine to spark deep discussion and connection in a small group. These local, self-organized events are branded TEDx, where x = independently organized TED event. The TED Conference provides general guidance for the TEDx program, but individual TEDx events are self-organized.* (*Subject to certain rules and regulations)From:TEDxTalksViews:254 19ratingsTime:12:51More inScience Technology

More:
Biotech and the Hungry Planet:Neal Carter at TEDxPenticton - Video

hERG SCREENING Technology, biotechnology, screening
Aarkstore.in announce 20% discount on this report Discount till 31st Dec. 2012 - hERG SCREENING | Technology, biotechnology, screeningFrom:Anjali KalanViews:0 0ratingsTime:00:13More inScience Technology

Read the original here:
hERG SCREENING Technology, biotechnology, screening - Video

BIOLOGICAL IMPLANTS Technology, biotechnology
From:Anjali KalanViews:1 0ratingsTime:00:14More inScience Technology

View post:
BIOLOGICAL IMPLANTS Technology, biotechnology - Video

BIONANOTECHNOLOGY Technology, biotechnology
From:Anjali KalanViews:0 0ratingsTime:00:15More inScience Technology

The rest is here:
BIONANOTECHNOLOGY Technology, biotechnology - Video

FEED NUCLEOTIDES Technology, biotechnology
From:Anjali KalanViews:0 0ratingsTime:00:13More inScience Technology

Link:
FEED NUCLEOTIDES Technology, biotechnology - Video

Passfail.com News: Friday Sector Leaders: Metals Mining, Biotechnology Stocks
In trading on Friday, metals mining shares were relative leaders, up on the day by about 1.9%. Leading the group were shares of Prospect Global Resources (PGRX), up about 17.4% and shares of Oxford Resource Partners Limited (OXF) up about 7.4% on the day. Also showing relative strength are biotechnology shares, up on the day by about 1.3% as a group, led by Biocryst Pharmaceuticals (BCRX), trading higher by about 59.4% and Savient Pharmaceuticals (SVNT), trading higher by about 21.6% on Friday. This is Sayoko Murase for Passfail.com, taking you behind the ticker. For Passfail.com, Behind The Ticker (TM) Pass Fail NewsFrom:passfailtvViews:0 0ratingsTime:00:46More inNews Politics

Read more:
Passfail.com News: Friday Sector Leaders: Metals

West Coast Market Fundamentals Appealing
http://www.reit.com John Kilroy, president and CEO of Kilroy Realty Corp. (NYSE KRC), joined REIT.com for a CEO Spotlight video interview at REITWorld 2012: NAREIT #39;s Annual Convention for All Things REIT at the Manchester Grand Hyatt in San Diego. Kilroy Realty has operated in West Coast commercial real estate markets for more than six decades. The firm operates a portfolio of high quality commercial properties totaling more than 15 million square feet that span coastal market locations from Seattle to San Diego. The company has a broadly diversified roster of industries, including firms specializing in technology, telecommunications, engineering, entertainment, healthcare, biotechnology and professional services. Kilroy Realty has its headquarters in Los Angeles and became a publicly traded REIT in 1997. Kilroy offered some insight into his company #39;s sale of its portfolio of industrial assets. "A couple years ago when the downturn hit, we knew there would be terrific opportunities up and down the West Coast. We had largely been Southern California-based, and we really saw an opportunity when the market fell apart to reposition ourselves and take advantage of being the premier West Coast player," Kilroy said. "The industrial just didn #39;t fit into that, because we #39;re primarily office. We have since become the largest REIT on the West Coast. We have the dominant footprint from Seattle to San Diego. It #39;s almost all office." Kilroy discussed the market fundamentals in the office ...From:NAREIT1Views:3 0ratingsTime:04:11More inNews Politics

View post:
West Coast Market Fundamentals Appealing - Video

Tissue Engineering for Clinical Applications: Faculty Insight with Sujata Bhatia
In this faculty insight, Dr. Sujata Bhatia discusses the current state of tissue engineering research and its exciting clinical applications. She also highlights the important work of Suniel Seetharam, an Extension School biotechnology graduate student who is developing new wound closure technology to mimic the feel and elasticity of real human skin. Dr. Bhatia is the assistant director of undergraduate studies in biomedical engineering at the Harvard School of Engineering and Applied Sciences. She also teaches the course "Tissue Engineering for Clinical Applications," http://www.extension.harvard.edu at Harvard Extension School. Faculty Insights are produced in partnership with Jenny Attiyeh and ThoughtCast.From:HarvardExtensionViews:19 1ratingsTime:07:41More inEducation

Read the rest here:
Tissue Engineering for Clinical Applications: Faculty Insight with Sujata Bhatia - Video

NCSU MB 351 Food Spoilage
References: Alfaro, Danilo. "Food Poisoning and Food Spoilage." Culinary Arts. About.com, nd Web. 19 Sept. 2012. culinaryarts.about.com Bailey, Regina. "Bacteria and Food Poisoning." Biology. About.com, nd Web. 19 Sept. 2012. biology.about.com Blackburn, Clive De W, ed. Food Spoilage Microorganisms. Woodhead Publishing, 2006. Knovel. Web. 19 Sept. 2012. http://www.knovel.com Edublogs.org. "Beano Lab." Brebeuf Jesuit Biotechnology, 2012. Web. 30 Oct. 2012. bjpsbiotech.edublogs.org Eye Of Science. "Bacillus Coagulans, SEM." Science Photo Library. Np, nd Web. 30 Oct. 2012. http://www.sciencephoto.com Fischer, Peter. "Molding Bread as a Natural Clock." The Age Of The Earth And The Formation Of The Universe. Timothy H. Heaton, 2005. Web. 30 Oct. 2012. orgs.usd.edu "Food Contamination and Spoilage." Hygiene And Environmental Health HEAT Module. LabSpace, nd Web. 19 Sept. 2012. labspace.open.ac.uk "Food Spoilage and Additives." Biotopics.co.uk, nd Web. 6 Oct. 2012. http://www.biotopics.co.uk "Hardychrom Candida." Hardy Diagnostics. Hugo: Hardy User Group Observer, 1996. Web. 30 Oct. 2012. catalog.hardydiagnostics.com "Kenya Could Save Millions of Shillings If It Can Make Use of a Fungus Which Reduces Aflatoxins in Cereal Crops."Organic Farmer Magazine. The Organic Farmer, Sept. 2010. Web. http://www.organicfarmermagazine.org Mouldy Foods, Cheese, Bread, and Fruit." Science Photo Library. Science Photo, nd Web. 30 http://www.sciencephoto.com "Preservation of Foods." Army Medical. Integrated Publishing, nd Web. 19 ...From:Kristen EgurenViews:7 0ratingsTime:09:50More inPeople Blogs

More here:
NCSU MB 351 Food Spoilage - Video

Biotechnology Youth Apprenticeship Program Field Trip
Students take a field trip to Biopharmaceutical Technology Center Institute in Madison, WI to learn more about the biotechnology field and biotechnology careers.From:WDBSCWViews:0 0ratingsTime:01:03More inEducation

More:
Biotechnology Youth Apprenticeship Program Field Trip - Video

Biosensors Technology, biotechnology ,Diagnostics, Pharma
From:Anjali KalanViews:0 0ratingsTime:00:13More inScience Technology

Here is the original post:
Biosensors Technology, biotechnology ,Diagnostics, Pharma - Video

APOPTOSIS Technology, Biotechnology ,Pathways ,Activators
From:Anjali KalanViews:0 0ratingsTime:00:13More inScience Technology

Original post:
APOPTOSIS Technology, Biotechnology ,Pathways ,Activators - Video

BAN ON GMO #39;s
The decision by government to ban the importation of genetically modified products in the country due to lack of evidence regarding their safety is puzzling and has raised eyebrows among stakeholders from various sectors in biotechnology who are suggesting a review on the importation of GMO #39;S in the country.From:gbskenyatvViews:1 0ratingsTime:03:15More inNews Politics

Read more:
BAN ON GMO's - Video

Deus Ex: Human Revolution on Mac #63743; Performance Gameplay Review
Performance tests on Macbook Air 11 Mid 2012, high settings, low fps, some lag spikes. Subcribe - http://www.youtube.com for more test and gameplay review of games on Mac, iPhone, iPad, iPod Touch. Ask any questions. Thanks for watching ! Deus Ex: Human Revolution is a cyberpunk-themed action role-playing video game developed by Eidos Montreal and published by Square Enix, which also produced the game #39;s CGI sequences. Released in August 2011, it is the third game in the Deus Ex series, and a prequel to the original game released in 2000. The Mac OS X version of the game, an "Ultimate Edition" which also contains The Missing Link downloadable content, is published by Feral Interactive and was released on April 26, 2012. The game is set in 2027, 25 years before the first game in the series, at a time when multinational corporations have grown in power beyond the control of national governments. The game follows Adam Jensen, the newly hired security director at Sarif Industries, a growing biotechnology firm. After terrorists brutally attack Sarif #39;s Detroit-based headquarters, the mortally wounded Jensen is forced to undergo radical life-saving surgeries that replace large areas of his body with advanced prostheses. Returning to work, he becomes embroiled in the global politics of the human enhancement movement in the search for those responsible for the attack. A central theme to the game is the rise of corporations in globalization, espionage, human survival, poverty and the ...From:iGameplay1337Views:3 2ratingsTime:05:42More inGaming

Read more:
Deus Ex: Human Revolution on Mac  Performance Gameplay Review - Video

OSDD Experts Voices - Chief Mentor, Prof Samir K Brahmachari, DG CSIR, (I)
OSDD is a CSIR led team India Consortium with global partnership with a vision to provide affordable healthcare to the developing world by providing a global platform where the best minds can collaborate collectively endeavor to solve the complex problems associated with discovering novel therapies for neglected tropical diseases like Malaria, Tuberculosis, Leshmaniasis, etc.OSDD is a translational platform for drug discovery, bringing together informaticians, wet lab scientists, contract research organizations, clinicians, hospitals and others who are willing to adhere to the affordable healthcare philosophy. It is a concept to collaboratively aggregate the biological, genetic and chemical information available to scientists in order to use it to hasten the discovery of drugs. This will provide a unique opportunity for scientists, doctors, technocrats, students and others with diverse expertise to work for a common cause. The success of Open Source models in Information Technology (For eg, Web Technology, The Linux Operating System) and Biotechnology (For eg, Human Genome Sequencing) sectors highlights the urgent need to initiate a similar model in healthcare, ie, an Open Source model for Drug Discovery. Council of Scientific and Industrial Research (www.csir.res.in) India is one of the largest publicly funded research organizations in the world. CSIR has played a key role in the development of industry in India by providing them with technologies. In particular, it ...From:osddvoicesViews:6 0ratingsTime:04:11More inScience Technology

See more here:
OSDD Experts Voices - Chief Mentor, Prof Samir K Brahmachari, DG CSIR, (I) - Video

OSDD Experts Voices - Chief Mentor, Prof Samir K Brahmachari, DG CSIR, (II)
OSDD is a CSIR led team India Consortium with global partnership with a vision to provide affordable healthcare to the developing world by providing a global platform where the best minds can collaborate collectively endeavor to solve the complex problems associated with discovering novel therapies for neglected tropical diseases like Malaria, Tuberculosis, Leshmaniasis, etc.OSDD is a translational platform for drug discovery, bringing together informaticians, wet lab scientists, contract research organizations, clinicians, hospitals and others who are willing to adhere to the affordable healthcare philosophy. It is a concept to collaboratively aggregate the biological, genetic and chemical information available to scientists in order to use it to hasten the discovery of drugs. This will provide a unique opportunity for scientists, doctors, technocrats, students and others with diverse expertise to work for a common cause. The success of Open Source models in Information Technology (For eg, Web Technology, The Linux Operating System) and Biotechnology (For eg, Human Genome Sequencing) sectors highlights the urgent need to initiate a similar model in healthcare, ie, an Open Source model for Drug Discovery. Council of Scientific and Industrial Research (www.csir.res.in) India is one of the largest publicly funded research organizations in the world. CSIR has played a key role in the development of industry in India by providing them with technologies. In particular, it ...From:osddvoicesViews:9 0ratingsTime:07:36More inScience Technology

View post:
OSDD Experts Voices - Chief Mentor, Prof Samir K Brahmachari, DG CSIR, (II) - Video

OSDD Experts Voices - Chief Mentor, Prof Samir K Brahmachari, DG CSIR, (III)
OSDD is a CSIR led team India Consortium with global partnership with a vision to provide affordable healthcare to the developing world by providing a global platform where the best minds can collaborate collectively endeavor to solve the complex problems associated with discovering novel therapies for neglected tropical diseases like Malaria, Tuberculosis, Leshmaniasis, etc.OSDD is a translational platform for drug discovery, bringing together informaticians, wet lab scientists, contract research organizations, clinicians, hospitals and others who are willing to adhere to the affordable healthcare philosophy. It is a concept to collaboratively aggregate the biological, genetic and chemical information available to scientists in order to use it to hasten the discovery of drugs. This will provide a unique opportunity for scientists, doctors, technocrats, students and others with diverse expertise to work for a common cause. The success of Open Source models in Information Technology (For eg, Web Technology, The Linux Operating System) and Biotechnology (For eg, Human Genome Sequencing) sectors highlights the urgent need to initiate a similar model in healthcare, ie, an Open Source model for Drug Discovery. Council of Scientific and Industrial Research (www.csir.res.in) India is one of the largest publicly funded research organizations in the world. CSIR has played a key role in the development of industry in India by providing them with technologies. In particular, it ...From:osddvoicesViews:1 0ratingsTime:05:45More inScience Technology

Continued here:
OSDD Experts Voices - Chief Mentor, Prof Samir K Brahmachari, DG CSIR, (III) - Video

OSDD Experts Voices - OSDD in a new phase Dr Balganesh Head OSDD UNIT
OSDD is a CSIR led team India Consortium with global partnership with a vision to provide affordable healthcare to the developing world by providing a global platform where the best minds can collaborate collectively endeavor to solve the complex problems associated with discovering novel therapies for neglected tropical diseases like Malaria, Tuberculosis, Leshmaniasis, etc.OSDD is a translational platform for drug discovery, bringing together informaticians, wet lab scientists, contract research organizations, clinicians, hospitals and others who are willing to adhere to the affordable healthcare philosophy. It is a concept to collaboratively aggregate the biological, genetic and chemical information available to scientists in order to use it to hasten the discovery of drugs. This will provide a unique opportunity for scientists, doctors, technocrats, students and others with diverse expertise to work for a common cause. The success of Open Source models in Information Technology (For eg, Web Technology, The Linux Operating System) and Biotechnology (For eg, Human Genome Sequencing) sectors highlights the urgent need to initiate a similar model in healthcare, ie, an Open Source model for Drug Discovery. Council of Scientific and Industrial Research (www.csir.res.in) India is one of the largest publicly funded research organizations in the world. CSIR has played a key role in the development of industry in India by providing them with technologies. In particular, it ...From:osddvoicesViews:2 0ratingsTime:07:49More inScience Technology

Read the rest here:
OSDD Experts Voices - OSDD in a new phase Dr Balganesh Head OSDD UNIT - Video

Background:
Cost-efficient generation of second-generation biofuels requires plant biomass that can easily be degraded into sugars and further fermented into fuels. However, lignocellulosic biomass is inherently recalcitrant toward deconstruction technologies due to the abundant lignin and cross-linked hemicelluloses. Furthermore, lignocellulosic biomass has a high content of pentoses, which are more difficult to ferment into fuels than hexoses. Engineered plants with decreased amounts of xylan in their secondary walls have the potential to render plant biomass a more desirable feedstock for biofuel production.
Results:
Xylan is the major non-cellulosic polysaccharide in secondary cell walls, and the xylan deficient irregular xylem (irx) mutants irx7, irx8 and irx9 exhibit severe dwarf growth phenotypes. The main reason for the growth phenotype appears to be xylem vessel collapse and the resulting impaired transport of water and nutrients. We developed a xylan-engineering approach to reintroduce xylan biosynthesis specifically into the xylem vessels in the Arabidopsis irx7, irx8 and irx9 mutant backgrounds by driving the expression of the respective glycosyltransferases with the vessel-specific promoters of the VND6 and VND7 transcription factor genes. The growth phenotype, stem breaking strength, and irx morphology was recovered to varying degrees. Some of the plants even exhibited increased stem strength compared to the wild type. We obtained Arabidopsis plants with up to 23% reduction in xylose levels and 18% reduction in lignin content compared to wild-type plants, while exhibiting wild-type growth patterns and morphology, as well as normal xylem vessels. These plants showed a 42% increase in saccharification yield after hot water pretreatment. The VND7 promoter yielded a more complete complementation of the irx phenotype than the VND6 promoter.
Conclusions:
Spatial and temporal deposition of xylan in the secondary cell wall of Arabidopsis can be manipulated by using the promoter regions of vessel-specific genes to express xylan biosynthetic genes. The expression of xylan specifically in the xylem vessels is sufficient to complement the irx phenotype of xylan deficient mutants, while maintaining low overall amounts of xylan and lignin in the cell wall. This engineering approach has the potential to yield bioenergy crop plants that are more easily deconstructed and fermented into biofuels.Source:
http://www.biotechnologyforbiofuels.com/content/5/1/84

Episode 6. A Milestone in New Medicines
PART 1 #65306;TaiMed Biologics -- A New Weapon in the Fight Against AIDS PART 2 #65306;TTY Biopharm -- Relieves the Burden on Hemophiliacs PART 3 #65306;Optimer Biotechnology -- Using Sugar Molecules to Create Cancer VaccineFrom:ccleestagViews:0 0ratingsTime:25:20More inScience Technology

Read more here:
Episode 6. A Milestone in New Medicines - Video